Skip to main content

Medline Inc Cl A(MDLN-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low44.24
Day High45.13
Open:44.66
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Tipranks
Analysts Are Bullish on These Healthcare Stocks: Telix Pharmaceuticals (TLPPF), Medline (MDLN)
GlobeNewswire
Medline to report first quarter 2026 results on May 6, 2026
Tipranks
Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX), Medline (MDLN) and Collegium Pharmaceutical (COLL)
Tipranks
Analysts Are Bullish on These Healthcare Stocks: Medline (MDLN), Protagonist Therapeutics (PTGX)
Tipranks
Barclays Remains a Buy on Medline (MDLN)
GlobeNewswire
Medline Inc. announces closing of secondary offering of Class A common stock and full exercise of underwriters’ option to purchase additional shares
Tipranks
Analysts Are Bullish on These Healthcare Stocks: Dexcom (DXCM), Medline (MDLN)
GlobeNewswire
Medline Inc. announces pricing of secondary offering of class A common stock
Tipranks
Analysts’ Top Healthcare Picks: Trulieve Cannabis (TCNNF), Medline (MDLN)
GlobeNewswire
Medline Inc. announces launch of secondary offering of Class A common stock
Tipranks
TD Cowen Remains a Buy on Medline (MDLN)
Tipranks
Analysts Conflicted on These Healthcare Names: Medline, Inc. Class A (MDLN), MannKind (MNKD) and Arvinas Holding Company (ARVN)
Tipranks
RBC Capital Sticks to Their Buy Rating for Medline, Inc. Class A (MDLN)
Tipranks
Analysts Offer Insights on Healthcare Companies: Medline, Inc. Class A (MDLN), Mirum Pharmaceuticals (MIRM) and Alcon (ALC)
Tipranks
Analysts Offer Insights on Healthcare Companies: Schrodinger (SDGR), Medline, Inc. Class A (MDLN) and Silence Therapeutics (SLN)
Tipranks
Analysts Offer Insights on Healthcare Companies: Medline, Inc. Class A (MDLN), Mirum Pharmaceuticals (MIRM) and Revolution Medicines (RVMD)
Tipranks
Analysts Offer Insights on Healthcare Companies: Medline, Inc. Class A (MDLN) and MannKind (MNKD)
GlobeNewswire
Medline Reports Fourth Quarter and Full Year 2025 Results
Tipranks
Analysts Offer Insights on Healthcare Companies: Beta Bionics, Inc. (BBNX), Medline, Inc. Class A (MDLN) and Palatin Technologies (PTN)
GlobeNewswire
Medline announces participation in the Barclays 28th Annual Global Healthcare Conference
Motley Fool
Symbotic Could Be a Massive Breakout Stock in 2026 After a 150% Surge in 2025
Motley Fool
How the Largest IPO of 2025 Could Be Healthy for Your Portfolio
Tipranks
Medline, Inc. Class A (MDLN) Gets a Buy from RBC Capital
GlobeNewswire
Medline to report fourth quarter and full year 2025 results on February 25, 2026
Tipranks
Medline price target raised to $55 from $50 at BTIG
Tipranks
2 New IPO Stocks Hit the Market – Morgan Stanley Picks the Superior One to Buy
MarketBeat
A Fresh IPO That Long-Term Investors Shouldn’t Ignore
MarketBeat.com
Tipranks
Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX) and Medline, Inc. Class A (MDLN)
Tipranks
Analysts Offer Insights on Healthcare Companies: Neumora Therapeutics, Inc. (NMRA), Medline, Inc. Class A (MDLN) and Tecan Group AG (OtherTCHBF)
Tipranks
Analysts Are Bullish on These Healthcare Stocks: Exagen (XGN), Medline, Inc. Class A (MDLN)
Tipranks
Analysts Offer Insights on Healthcare Companies: Medline, Inc. Class A (MDLN) and IDEAYA Biosciences (IDYA)
Motley Fool
Motley Fool Money: The Most Shocking Stories of 2025

Profile

Medline Inc. is a provider of medical surgical products and supply chain solutions serving all points of care. Medline Inc. is headquartered in Northfield, Illinois.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.